Corona, Pablo S. http://orcid.org/0000-0003-4128-3142
Pérez, Marta http://orcid.org/0000-0001-5002-8034
Vicente, Matías http://orcid.org/0000-0002-9404-9299
Pujol, Oriol http://orcid.org/0000-0003-4760-2730
Amat, Carles http://orcid.org/0000-0002-3057-0595
Carrera, Lluís http://orcid.org/0000-0002-9936-7923
Funding for this research was provided by:
Universitat Autònoma de Barcelona
Article History
Received: 4 January 2023
Accepted: 10 April 2023
First Online: 20 April 2023
Declarations
:
: All Authors: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. One of the authors (Pablo S. Corona) has done paid speaking engagements at scientific conferences during the thirty-six months prior to submission of this work, to an entity in the biomedical arena (Tecres SpA, Sommacampagna–VR, Italy and Waldemar Link GmbH & Co.; Germany) whose products have been mentioned in the article. The author does not have any other conflict of interest with said companies. No author has had any other relationships, or has engaged in any other activities that could be perceived to influence or have the potential to influence what is written in this work.
: The Drug and Clinical Research Ethics Committee of Vall d’Hebron University Hospital approved this study (date: 13/11/2020, reference number: PR(ATR)283/2020).
: Informed consent was obtained from all individual participants included in the study.
: Consent to publish was received from all individual participants included in the study.